[{"address1": "Ole Maal\u00f8es Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 55, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 892238, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith", "age": 55, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 503280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 391236, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.22, "open": 1.24, "dayLow": 1.17, "dayHigh": 1.2702, "regularMarketPreviousClose": 1.22, "regularMarketOpen": 1.24, "regularMarketDayLow": 1.17, "regularMarketDayHigh": 1.2702, "beta": 0.466, "forwardPE": -1.0341882, "volume": 164858, "regularMarketVolume": 164858, "averageVolume": 414573, "averageVolume10days": 101970, "averageDailyVolume10Day": 101970, "marketCap": 81692312, "fiftyTwoWeekLow": 0.733, "fiftyTwoWeekHigh": 2.098, "fiftyDayAverage": 1.16944, "twoHundredDayAverage": 1.413365, "currency": "USD", "enterpriseValue": -18881094, "floatShares": 27841933, "sharesOutstanding": 65880900, "sharesShort": 277050, "sharesShortPriorMonth": 122135, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0042, "heldPercentInsiders": 0.00235, "heldPercentInstitutions": 0.76658994, "shortRatio": 0.38, "shortPercentOfFloat": 0.0115, "impliedSharesOutstanding": 67514304, "bookValue": 1.461, "priceToBook": 0.8281999, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -88004000, "trailingEps": -1.26, "forwardEps": -1.17, "enterpriseToEbitda": 0.203, "52WeekChange": 0.4069767, "SandP52WeekChange": 0.39389753, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IOBT", "underlyingSymbol": "IOBT", "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "firstTradeDateEpochUtc": 1636119000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ea2848e4-aa90-3bf4-82a5-9ce691c6a8c0", "messageBoardId": "finmb_1685354464", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.21, "targetHighPrice": 12.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.2, "targetMedianPrice": 8.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 100747000, "totalCashPerShare": 1.529, "ebitda": -93157000, "totalDebt": 2150000, "quickRatio": 7.417, "currentRatio": 7.845, "debtToEquity": 2.233, "returnOnAssets": -0.50976, "returnOnEquity": -0.87657, "freeCashflow": -51137124, "operatingCashflow": -80699000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-28"}]